RAYSEARCH Aktie

 

STOCKHOLM, June 27, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the release of RayCare®* v2025, the latest version of its next-generation oncology information system. The new release delivers powerful functionality enhancements that streamline clinical workflows,......

STOCKHOLM, June 16, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in the first European clinical treatments with Neutron Therapeutics' accelerator-based boron neutron capture therapy (BNCT),......

RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in the first European clinical treatments with Neutron Therapeutics' accelerator-based boron neutron capture therapy (BNCT), carried out on a patient at Helsinki University Hospital in Finland. RayStation supports BNCT planning by its suite of tools for patient modelling, plan setup and plan evaluation. In addition, there are specific adaptations for use with the Neutron Therapeutics machine including seamless connection to the BNCT dose engine provided by Neutron...

STOCKHOLM, June 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) will exhibit at PTCOG 63, held June 3-6, 2025, in Buenos Aires, Argentina. At booth #08, the company will showcase its latest software innovations driving the future of particle therapy. RaySearch's portfolio –......

Das Instrument 27R SE0000135485 RAYSEARCH LABS B SK 0,40 EQUITY wird ex Dividende/Zinsen gehandelt am 23.05.2025 The instrument 27R SE0000135485 RAYSEARCH LABS B SK 0,40 EQUITY has its ex-dividend/interest day on 23.05.2025...

The Annual General Meeting 2025 of RaySearch Laboratories AB (publ) was held on May 22, 2025, in Stockholm, Sweden. The following resolutions were adopted. STOCKHOLM, May 22, 2025 /PRNewswire/ -- It was resolved to re-elect Carl Filip Bergendal, Johan Löf, Günther Mårder, Britta Wallgren......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

STOCKHOLM, May 9, 2025 /PRNewswire/ -- FIRST QUARTER (JANUARY - MARCH 2025) Order intake amounted to SEK 409.6 M (238.5) Net sales amounted to SEK 331.7 M (257.2) Operating profit amounted to SEK 74.8 M (45.8) Profit after tax amounted to SEK 56.8 M (36.7) Earnings per share before/after......

STOCKHOLM, May 3, 2025 /PRNewswire/ -- At this week's ESTRO conference in Vienna, RaySearch Laboratories AB (publ) and Vision RT proudly announces the next step in their collaboration: the full integration of MapRT with RayStation®* treatment planning system. This integration enables full......

STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that The Royal Marsden NHS Foundation Trust in the UK has treated its first patient using a new and groundbreaking workflow, enabled by the new adaptive replanning module, released in the latest......

STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce our participation at ESTRO in Vienna, Austria, May 3-5, where we will present groundbreaking innovations under our new global campaign Coding Energy to End Cancer. Attendees will be able to book......

STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the launch of RayStation®* v2025, the latest version of the company's innovative treatment planning system. The new version comes with fast automated treatment planning using machine learning** and using the......

Oncospace Solutions to Integrate into Sun Nuclear Brand, Expand Radiation Therapy Quality Assurance Digital-Forward Strategy MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, today announced the acquisition of Oncospace, a company providing cloud-based, AI-powered solutions for the radiation oncology community. This strategic move underscores the Sun Nuclear commitment to leverage cutting-edge technology to improve treatment outcomes on behalf of our customers. Oncospace's AI and machine-learning technologies are designed to develop data-driven, physician-centric solutions that optimize patient outcomes. Since its inception in 2018, Oncospace has launched two main offerings: Gateway: A Treatment Planning Conversion solution for Philips Pinnacle users, which converts patient archives to modern treatment planning solutions, such as Raysearch Raystation and Varian Medical Systems® Eclipse. While originally developed for prostate treatments, this solution has since expanded to head an...

Earlier today, RaySearch Laboratories AB (publ) published its annual report for 2024. In the press release it was stated that the remuneration report was also published, which was incorrect.  The remuneration report will be published no later than May 1. The annual report in ESEF format is also attached to this press release. RaySearch's annual report for 2024 is available on RaySearch's website under the Investors section....

STOCKHOLM, April 25, 2025 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the first quarter of 2025, on May 9, 2025, at 10.00 am CEST. The report will be published on May 9, 2025, at 07.45 am and will be available together......

STOCKHOLM, April 25, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces that Odense University Hospital (OUH), which is part of the South Denmark Region, has placed an order for RayStation®*. The radiotherapy center at OUH is known for being at the forefront of automated......

Today, RaySearch Laboratories AB (publ) publishes its Annual Report and Remuneration Report for the financial year 2024. The reports are held available at RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 07:50 am CEST, on April 25, 2025....

RaySearch Laboratories AB (publ) announces that Odense University Hospital (OUH), which is part of the South Denmark Region, has placed an order for RayStation®*. The radiotherapy center at OUH is known for being at the forefront of automated solutions to provide high-quality care in an efficient way, including the ability to automatically generate treatment plans. With the introduction of RayStation, the clinic is now taking the next step by further developing automation to cover all aspects of the treatment planning process—from initial planning to finalized treatment plans. RayStation...

STOCKHOLM, April 14, 2025 /PRNewswire/ -- The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to be held on Thursday, May 22, 2025, at 6.00 p.m. at the company's office at Eugeniavägen 18C, Stockholm,......

According to the articles of association of RaySearch Laboratories AB (publ), owners of Class A shares have the right to have such shares converted to Class B shares. Such a conversion reduces the number of votes in the company. In March 2025, 2,000,000 Class A shares were converted to Class B shares, at the request of a shareholder. The total number of votes in RaySearch thereafter amounts to 85,177,548 votes. The total number of registered shares in RaySearch amounts to 34,282,773 shares, out of which 5,654,975 are Class A shares and 28,627,798 are Class B shares. This information is...